{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:57:22Z","timestamp":1779217042002,"version":"3.51.4"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.5512-25","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:12:17Z","timestamp":1777327937000},"source":"Crossref","is-referenced-by-count":1,"title":["Cervical Varicella-Zoster Virus Myelitis in a Patient Receiving Weekly Low-Dose Methotrexate"],"prefix":"10.2169","author":[{"given":"Naritaka","family":"Morikawa","sequence":"first","affiliation":[{"name":"Disease Control and Prevention Center, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kamegai","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Division of Rheumatic Diseases, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Aozaki","sequence":"additional","affiliation":[{"name":"Division of Rheumatic Diseases, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Hotta","sequence":"additional","affiliation":[{"name":"Division of Neurology, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Nomoto","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, Japan Institute for Health Security, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Laing KJ, Ouwendijk WJD, Koelle DM, Verjans GMGM. Immunobiology of varicella-zoster virus infection. J Infect Dis 218 (Supplement 2): S68-S74, 2018.","DOI":"10.1093\/infdis\/jiy403"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342: 635-645, 2000.","DOI":"10.1056\/NEJM200003023420906"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nagel MA, Gilden D. Neurological complications of varicella zoster virus reactivation. Curr Opin Neurol 27: 356-360, 2014.","DOI":"10.1097\/WCO.0000000000000092"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tao T, Chen J, Long K, et al. Severe varicella-zoster virus meningoencephalomyelitis coexisting with visceral disseminated varicella-zoster virus infection in a patient with lupus nephritis: A case report. Medicine (Baltimore) 102: e33459, 2023.","DOI":"10.1097\/MD.0000000000033459"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Kato H, Murakami T, Tajiri Y, Hanajima R. Successful early treatment with acyclovir and corticosteroids for acute myelitis associated with zoster sine herpete: A case report. Rinsho Shinkeigaku 60: 485-488, 2020.","DOI":"10.5692\/clinicalneurol.60.cn-001426"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Thomas JE, Howard FM. Segmental zoster paresis-a disease profile. Neurology 22: 459-466, 1972.","DOI":"10.1212\/WNL.22.5.459"},{"key":"7","unstructured":"7. Johnson R, Milbourn PE. Central nervous system manifestations of chickenpox. Can Med Assoc J 102: 831-834, 1970."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sellner J, Hemmer B, M\u00fchlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 34: 371-379, 2010.","DOI":"10.1016\/j.jaut.2009.09.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rubin LG, Levin MJ, Ljungman P, et al. IDSA clinical practice guideline for vaccination of the immunocompromised Host. Clin Infect Dis 2013: e44, 2024-01-21.","DOI":"10.1093\/cid\/cit684"},{"key":"10","unstructured":"10. Zhang N, Wilkinson S, Riaz M, \u00d6st\u00f6r AJK, Nisar MK. Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review. Clin Exp Rheumatol 30: 962-971, 2012."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hung CH, Chang KH, Kuo HC, et al. Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci 318 (1-2): 19-24, 2012. 2012.","DOI":"10.1016\/j.jns.2012.04.017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant 15: 1143-1238, 2009.","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"13","unstructured":"13. Fragoulis GE, Nikiphorou E, Dey M, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 82: 742-753, 2023."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372: 2087-2096, 2015.","DOI":"10.1056\/NEJMoa1501184"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Schwarz TF, Volpe S, Catteau G, et al. Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults. Hum Vaccin Immunother 14: 1370-1377, 2018.","DOI":"10.1080\/21645515.2018.1442162"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Strezova A, Diez-Domingo J, Al Shawafi K, et al. Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: interim efficacy, immunogenicity, and safety results up to 10 years after initial vaccination. Open Forum Infect Dis 9: ofac485, 2022.","DOI":"10.1093\/ofid\/ofac492.192"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Ikematsu H, Yamashita N, Ogawa M, Hirano M, Kovac M, Watanabe D. Efficacy, safety and immunogenicity of a novel adjuvanted subunit herpes zoster vaccine in Japanese aged 50 years and 70 years and older. Kansenshogaku Zasshi 92: 103-114, 2018.","DOI":"10.11150\/kansenshogakuzasshi.92.103"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aoyagi J, Kanai T, Maru T, et al. Efficacy of plasma exchange with a high dose of acyclovir for disseminated varicella infection. CEN Case Rep 9: 15-18, 2020.","DOI":"10.1007\/s13730-019-00415-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takahashi T, Tamura M, Miki K, et al. Varicella zoster virus myelitis in two elderly patients: diagnostic value of nested polymerase chain reaction assay and antibody index for cerebrospinal fluid specimens. Case Rep Neurol 5: 81-90, 2013 Apr 12.","DOI":"10.1159\/000350714"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yoo JH, Kim HJ, Park KD, Lee JK, Lim OK. Acute transverse myelitis after varicella-zoster virus infection in an immunocompetent patient: A Case report. J Electrodiagn Neuromuscul Dis 24: 32-37, 2022.","DOI":"10.18214\/jend.2021.00122"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 70: 853-860, 2008.","DOI":"10.1212\/01.wnl.0000304747.38502.e8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 8: 731-740, 2009.","DOI":"10.1016\/S1474-4422(09)70134-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Meyding-Lamad\u00e9 UK, Oberlinner C, Rau PR, et al. Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 9 (1): 118-125, 2003.","DOI":"10.1080\/13550280390173373"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ramos-Estebanez C, Lizarraga KJ, Merenda A. A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy? Antivir Ther 19 (2): 133-139, 2014.","DOI":"10.3851\/IMP2683"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bradshaw MJ, Venkatesan A. Herpes simplex Virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics 13: 493-508, 2016.","DOI":"10.1007\/s13311-016-0433-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_5512-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:21:25Z","timestamp":1777692085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_5512-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5512-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"5512-25"}}